Reduced expression of the retinoblastoma protein shows that the related signaling pathway is essential for mediating the antineoplastic activity of erufosine.
Erufosine is a new antineoplastic agent of the group of alkylphosphocholines, which interferes with signal transduction and induces apoptosis in various leukemic and tumor cell lines. The present study was designed to examine for the first time the mechanism of resistance to erufosine in malignant c...
Enregistré dans:
Auteurs principaux: | Maya M Zaharieva, Milen Kirilov, Minquang Chai, Stefan M Berger, Spiro Konstantinov, Martin R Berger |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b1d12f7a84f64cbf9ebb18b8f19d9578 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Antineoplastics Encapsulated in Nanostructured Lipid Carriers
par: Gustavo Henrique Rodrigues da Silva, et autres
Publié: (2021) -
Retinoblastoma
par: Marchevsky,Silvia, et autres
Publié: (1979) -
Tumor targeting using liposomal antineoplastic drugs
par: Jörg Huwyler, et autres
Publié: (2008) -
Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway
par: Shu Wen, et autres
Publié: (2021) -
The Interference of COVID-19 in the Oral Cancer Diagnosis and Antineoplastic Treatment
par: Correia-Neto,Ivan José, et autres
Publié: (2021)